Thus, studies assessing the relationship between GPA, IFA, TNF-α, IL-6 as well as cardiometabolic risk factors and vitamin B12 deficiency among metformin-treated T2DM patients are warranted. Here, TNF is linked to vitamin B12 deficiency.